Cargando…
Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases
BACKGROUND: Drug repurposing, the process of identifying additional therapeutic uses for existing drugs, has attracted increasing attention from both the pharmaceutical industry and the research community. Many existing computational drug repurposing methods rely on preclinical data (e.g., chemical...
Autores principales: | Wen, Qianlong, Liu, Ruoqi, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461864/ https://www.ncbi.nlm.nih.gov/pubmed/34560862 http://dx.doi.org/10.1186/s12911-021-01617-4 |
Ejemplares similares
-
Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection
por: Correia, Ana Salomé, et al.
Publicado: (2023) -
K-Map: connecting kinases with therapeutics for drug repurposing and development
por: Kim, Jihye, et al.
Publicado: (2013) -
Reconciling multiple connectivity scores for drug repurposing
por: Samart, Kewalin, et al.
Publicado: (2021) -
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
por: Liu, Tsang-Pai, et al.
Publicado: (2018) -
Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
por: Liu, Ruoqi, et al.
Publicado: (2019)